This inventor holds 1 USPTO granted patent. Top assignee: Development Center for Biotechnology. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Hsin-Hua Chou: Innovator in Biochemistry
Introduction
Hsin-Hua Chou is a prominent inventor based in Taipei, Taiwan. She has made significant contributions to the field of biochemistry, particularly in the development of novel enzymes for pharmaceutical applications. Her work has led to advancements in the production of important compounds used in medicine.
Latest Patents
Hsin-Hua Chou holds a patent for a mutant D-amino acid aminotransferase, which is designed for simultaneously producing glutaryl-7-aminocephalosporanic acid and D-amino acid. The invention relates to the substitution of the glutamate residue at position 13 of the wild type D-amino acid aminotransferase with hydrophobic amino acids. This innovative enzyme can be utilized in the production of D-amino acid and the conversion of glutaryl-7-aminocephalosporanic acid from cephalosporin C. The patent also includes a replica-paper staining method for screening cells that express high DAT activity. Hsin-Hua Chou has 1 patent to her name.
Career Highlights
Hsin-Hua Chou is affiliated with the Development Center for Biotechnology, where she continues to engage in groundbreaking research. Her work has not only advanced scientific knowledge but has also contributed to practical applications in the pharmaceutical industry.
Collaborations
Hsin-Hua Chou has collaborated with notable colleagues, including Szu-Pei Wu and Edward Yi Chang. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Hsin-Hua Chou's contributions to biochemistry and her innovative patent demonstrate her commitment to advancing science and technology. Her work continues to impact the field positively, paving the way for future developments in pharmaceutical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
